Theravance Biopharma, Inc.
DE ˙ DB ˙ KYG8807B1068
13,60 € ↑0,30 (2,26%)
2026-06-04
DEL PRIS
SecurityDE:0TB / Theravance Biopharma, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership510,272 shares
Latest Disclosed Value $ 8,281,715
Morgan Stanley reports 36.46% decrease in ownership of 0TB / Theravance Biopharma, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 510,272 shares of Theravance Biopharma, Inc. (DE:0TB) valued at $6,735,590 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 803,119 shares of Theravance Biopharma, Inc.. This represents a change in shares of -36.46% during the quarter. The current value of the position is $6,939,699 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 510,272 -292,847 -36.46 8,282 -44.89 0.0005
2026-05-27 2025-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 803,119 203,568 33.95 15,026 71.67 0.0009
2026-02-13 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 803,119 203,568 15,026 0.0009
2026-05-27 2025-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 599,551 48,944 8.89 8,753 44.13 0.0005
2025-11-14 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 599,551 48,944 8,753 0.0005
2025-08-15 2025-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 550,607 165,620 43.02 6,073 76.69 0.0004
2025-05-15 2025-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 384,987 -7,346 -1.87 3,438 -6.88 0.0002
2025-05-15 2024-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 392,333 -103,480 -20.87 3,692 -7.63 0.0003
2025-02-14 2024-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 392,333 -103,480 3,692 0.0003
2025-05-14 2024-09-30 13F/A-2 THERAVANCE BIOPHARMA COM G8807B106 495,813 36,890 8.04 3,996 2.70 0.0003
2025-02-14 2024-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 495,813 36,890 3,996 0.0003
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 495,813 36,890 3,996 0.0000
2025-05-14 2024-06-30 13F/A-2 THERAVANCE BIOPHARMA COM G8807B106 458,923 39,810 9.50 3,892 3.51 0.0003
2024-10-17 2024-06-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 458,923 39,810 3,892 0.0003
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 458,923 39,810 3,892 0.0003
2024-10-17 2024-03-31 13F/A-2 THERAVANCE BIOPHARMA COM G8807B106 419,113 155,664 59.09 3,759 26.95 0.0003
2024-08-16 2024-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 419,113 155,664 3,759 0.0000
2024-05-15 2024-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 419,113 155,664 3,759 0.0003
2024-08-16 2023-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 263,449 10,828 4.29 2,961 35.83 0.0003
2024-02-13 2023-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 263,449 10,828 2,961 0.0003
2023-11-15 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 252,621 29,394 13.17 2,180 -5.63 0.0002
2023-08-14 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 223,227 -129,676 -36.75 2,310 -39.66 0.0002
2023-05-15 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 352,903 -134,920 -27.66 3,829 -30.06 0.0004
2023-02-14 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 487,823 -110,842 -18.51 5,473 -9.84 0.0006
2022-11-14 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 598,665 205,080 52.11 6,070 70.27 0.0008
2022-10-27 2022-06-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 393,585 -276,419 -41.26 3,565 -44.34 0.0005
2022-08-15 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 393,585 -276,419 3,565 0.0005
2022-10-27 2022-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 670,004 -809,025 -54.70 6,405 -60.81 0.0009
2022-05-13 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 670,004 -809,025 6,405 0.0009
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 1,479,029 950,477 179.83 16,343 317.98 0.0020
2021-11-15 2021-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 528,552 80,582 17.99 3,910 -39.88 0.0005
2021-08-23 2021-06-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 447,970 289,099 181.97 6,504 100.62 0.0009
2021-08-16 2021-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 447,970 289,099 6,504 0.0002
2021-05-17 2021-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 158,871 -431,110 -73.07 3,242 -69.07 0.0005
2021-02-16 2020-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 589,981 467,538 381.84 10,483 479.17 0.0016
2020-11-13 2020-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 122,443 -280,092 -69.58 1,810 -78.57 0.0004
2020-08-14 2020-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 402,535 -145,135 -26.50 8,448 -33.25 0.0019
2020-05-26 2020-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 547,670 -57,186 -9.45 12,656 -19.18 0.0034
2020-05-15 2020-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 547,670 -57,186 12,656 972.2446
2020-02-14 2019-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 604,856 100,848 20.01 15,660 59.49 0.0036
2019-11-14 2019-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 504,008 -55,082 -9.85 9,819 7.55 0.0026
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 559,090 -128,302 -18.67 9,130 -41.41 0.0024
2019-05-15 2019-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 687,392 61,241 9.78 15,584 -2.74 0.0044
2019-02-14 2018-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 626,151 508,426 431.88 16,023 316.61 0.0048
2019-04-23 2018-09-30 13F/A-2 THERAVANCE BIOPHARMA COM G8807B106 117,725 15,919 15.64 3,846 66.64 0.0010
2018-11-20 2018-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 117,725 0 3,846 0.0010
2018-11-14 2018-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 117,725 15,919 3,846
2019-04-23 2018-06-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 101,806 154 0.15 2,308 -6.37 0.0006
2018-08-14 2018-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 101,806 154 2,308
2019-04-23 2018-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 101,652 5,415 5.63 2,465 -8.16 0.0007
2018-05-14 2018-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 101,652 5,415 2,465
2019-04-23 2017-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 96,237 33,051 52.31 2,684 24.03 0.0007
2018-02-14 2017-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 96,237 33,051 2,684
2017-11-14 2017-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 63,186 -10,620 -14.39 2,164 -26.39 0.0006
2017-08-11 2017-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 73,806 6,688 9.96 2,940 18.98 0.0009
2017-05-22 2017-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 67,118 -55,404 -45.22 2,471 -36.74 0.0008
2017-05-12 2017-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 67,118 2,471
2017-02-22 2016-12-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 122,522 95,272 349.62 3,906 295.74 0.0013
2017-02-13 2016-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 122,522 3,906
2016-11-10 2016-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 27,250 -5,547 -16.91 987 32.48 0.0003
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 32,797 24,983 319.72 745 406.80 0.0003
2016-05-12 2016-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 7,814 1,831 30.60 147 50.00 0.0001
2016-02-09 2015-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 5,983 444 8.02 98 60.66 0.0000
2016-02-08 2015-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 5,539 -16,055 -74.35 61 -78.29 0.0000
2015-11-09 2015-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 5,539 61
2015-08-12 2015-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 21,594 9,643 80.69 281 35.75 0.0001
2015-05-14 2015-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 11,951 -163,752 -93.20 207 -92.10 0.0001
2015-02-13 2014-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 175,703 80,845 85.23 2,621 19.84 0.0010
2014-12-16 2014-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 94,858 88,134 1,310.74 2,187 921.96 0.0008
2014-11-14 2014-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 94,858 2,187
2014-08-12 2014-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 6,724 6,724 214 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.